These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1820 related articles for article (PubMed ID: 18331727)

  • 21. Effects of benidipine, a dihydropyridine-Ca2+ channel blocker, on expression of cytokine-induced adhesion molecules and chemoattractants in human aortic endothelial cells.
    Matsubara M; Hasegawa K
    Eur J Pharmacol; 2004 Sep; 498(1-3):303-14. PubMed ID: 15364009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism underlying the block of human Cav3.2 T-type Ca2+ channels by benidipine, a dihydropyridine Ca2+ channel blocker.
    Inayoshi A; Sugimoto Y; Funahashi J; Takahashi S; Matsubara M; Kusaka H
    Life Sci; 2011 May; 88(19-20):898-907. PubMed ID: 21466810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes.
    Lalevée N; Rebsamen MC; Barrère-Lemaire S; Perrier E; Nargeot J; Bénitah JP; Rossier MF
    Cardiovasc Res; 2005 Aug; 67(2):216-24. PubMed ID: 15919070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of pranidipine on N-type voltage-dependent Ca2+ channels in mice.
    Murakami M; Mori T; Nakagawasai O; Hagiwara K; Sakurada Y; Mobarakeh II; Murata A; Yamadera F; Miyoshi I; Tan-No K; Yanai K; Tadano T; Iijima T
    Neurosci Lett; 2004 Aug; 367(1):118-22. PubMed ID: 15308311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
    Okayama S; Imagawa K; Naya N; Iwama H; Somekawa S; Kawata H; Horii M; Nakajima T; Uemura S; Saito Y
    Hypertens Res; 2006 Jul; 29(7):493-7. PubMed ID: 17044661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
    Seino H; Miyaguchi S; Yamazaki T; Ota S; Yabe R; Suzuki S
    Arzneimittelforschung; 2007; 57(8):526-31. PubMed ID: 17915639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II inhibition of Ca2+ currents is independent of ATR1 angiotensin II receptor activation in rat adult vagal afferent neurons.
    Moreira TH; Rodrigues AL; Beirão PS; dos Santos RA; Santos Cruz J
    Auton Neurosci; 2005 Feb; 117(2):79-86. PubMed ID: 15664560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of voltage-gated L-type calcium channels by labedipinedilol-A involves protein kinase C in rat cerebrovascular smooth muscle cells.
    Wu BN; Chen ML; Dai ZK; Lin YL; Yeh JL; Wu JR; Chen IJ
    Vascul Pharmacol; 2009; 51(2-3):65-71. PubMed ID: 19298869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
    Freeze BS; McNulty MM; Hanck DA
    Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking T-type calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells.
    Rossier MF; Python CP; Capponi AM; Schlegel W; Kwan CY; Vallotton MB
    Endocrinology; 1993 Mar; 132(3):1035-43. PubMed ID: 8382595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
    Melena J; Osborne NN
    Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertension.
    Tomino Y
    Curr Hypertens Rev; 2013 May; 9(2):108-14. PubMed ID: 23971692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrandrine and related bis-benzylisoquinoline alkaloids from medicinal herbs: cardiovascular effects and mechanisms of action.
    Kwan CY; Achike FI
    Acta Pharmacol Sin; 2002 Dec; 23(12):1057-68. PubMed ID: 12466042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II type 1 receptor activation modulates L- and T-type calcium channel activity through distinct mechanisms in bovine adrenal glomerulosa cells.
    Maturana AD; Burnay MM; Capponi AM; Vallotton MB; Rossier MF
    J Recept Signal Transduct Res; 1999; 19(1-4):509-20. PubMed ID: 10071781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voltage-gated calcium channel currents in type I and type II hair cells isolated from the rat crista.
    Bao H; Wong WH; Goldberg JM; Eatock RA
    J Neurophysiol; 2003 Jul; 90(1):155-64. PubMed ID: 12843307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of L- and T-type calcium channels in local and remote calcium responses in rat mesenteric terminal arterioles.
    Braunstein TH; Inoue R; Cribbs L; Oike M; Ito Y; Holstein-Rathlou NH; Jensen LJ
    J Vasc Res; 2009; 46(2):138-51. PubMed ID: 18765948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker.
    Yao K; Nagashima K; Miki H
    J Pharmacol Sci; 2006 Apr; 100(4):243-61. PubMed ID: 16565579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for regulation of mitochondrial function by the L-type Ca2+ channel in ventricular myocytes.
    Viola HM; Arthur PG; Hool LC
    J Mol Cell Cardiol; 2009 Jun; 46(6):1016-26. PubMed ID: 19166857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mibefradil metabolite is a potent intracellular blocker of L-type Ca(2+) currents in pancreatic beta-cells.
    Wu S; Zhang M; Vest PA; Bhattacharjee A; Liu L; Li M
    J Pharmacol Exp Ther; 2000 Mar; 292(3):939-43. PubMed ID: 10688607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca2+ channel inhibition in cultured vascular smooth muscle cells.
    Toshiro M; Ueno T; Tanaka M; Oka H; Miyamotq T; Osajima K; Matsumoto K
    Hypertens Res; 2005 Jun; 28(6):545-52. PubMed ID: 16231761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 91.